MedTrace Logo

An Outpatient Study Investigating Non-prescription Treatments for COVID-19

NCT04621149 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-09-30

No results posted yet for this study

Summary

This is a platform study to investigate the effectiveness of a variety of non-prescription approaches for the treatment of non-hospitalized adults recently tested positive for COVID-19.

Conditions

Interventions

OTHER

chlorine dioxide

chlorine dioxide is an antimicrobial agent used for a variety of purposes including as a water purification product, a disinfectant on food, etc.

DIETARY_SUPPLEMENT

zinc acetate

zinc acetate lozenges have been suggested to have antiviral properties

DRUG

Famotidine

famoitidine is a histamine-2 blocker sold over the counter to reduce stomach acid

OTHER

placebo

filtered water

DIETARY_SUPPLEMENT

lactoferrin, green tea extract

lactoferrin and green tea extract are dietary supplements

Sponsors & Collaborators

  • Profact, Inc.

    lead OTHER

Principal Investigators

  • Jonathan Murphy, MD, MD(H) · Profact, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2022-03-31
Completion
2022-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04621149 on ClinicalTrials.gov